🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🚀Incredible milestone from our industry colleagues at Integrated DNA Technologies and Aldevron—supporting the world’s first #mRNA-based personalized #CRISPR therapy! Thrilled to see #PrecisionMedicine advances make it to the bedside—and be part of the ecosystem making it possible! #GeneTherapy

In early-stage drug discovery, speed is important. Our Rapid Genes help you screen more targets in less time. They’re ready to use, NGS-verified, and perfect for quickly moving into your high throughput screening experiments. Learn more here: idtb.io/kei070

📣Calling all synthetic biology pioneers! Are you tired of bottlenecks in scale, testing and development? Do you want faster turnaround times? IDT's newly installed custom solutions programs is accepting new project requests! This program offers: ✅White glove manufacturing

#WorldEnvironmentDay 2025 calls for collective action to tackle plastic pollution—and at IDT, we’re doing our part by reducing plastic waste in our manufacturing and laboratory facilities. In fact, switching to liquid handling automation for the manufacture of our gene and gene

💥Your research deserves better fusion detection.💥 A study reanalyzing 663 solid tumor samples found that an opposing primer multiplex PCR missed 81% of fusions due to primer constraints. FUSIONPlex™ paired with Archer Analysis detected them—providing deeper insights for

We’re counting down the days to #ASM2025! Stop by booth #1723 to chat with IDT experts about our broad portfolio of #qPCR primers for #geneexpression and #pathogenresearch—including our new PrimeTime™ Research Pathogen Primers and Probes and the PrimeTime Influenza Kit. We’re

💻FREE WEBINAR💻 Can you discover more than fusions with your targeted #NGS #RNA assay? In our next webinar, the University of Iowa will present their experience using IDT Archer™ FUSIONPlex™ assays utilizing lung, thyroid, salivary gland tumors, and blood cancer samples.

🔬 Understanding the Genomic Landscape of #Neuroblastoma 🔬 A recent study from leading researchers explores the complex genetic drivers of neuroblastoma, emphasizing the importance of comprehensive genomic profiling in solid tumor research. Advances in targeted #NGS approaches,

Harness advanced multi-modal insights with our trusted partner, Molecular Health! Access our free report showcasing the transformative benefits of their tertiary analysis software here: idtb.io/sf46m4 #NGS #cancerresearch #multimodalsinsights

CALLING ALL #ASM2025 ATTENDEES! Do you want to own an IDT Yeti® mug? Sign up for our 20-minute focus group to provide feedback on your experience ordering online—from product search and customization to mobile usability and support. Spots are limited—sign up here:

"The future of CRISPR is here—and we’re just getting started." Sandy Ottensmann, VP/GM, gene writing and editing, reflects on the role IDT and Aldevron played in manufacturing the world’s first personalized #CRISPR therapy. Get a behind-the-scenes look here:

Are you looking for a comprehensive guide to help you leverage the transformative power of Whole Exome Sequencing (WES)? Our new ebook offers all of these critical insights to help empower actionable insights in your cancer research. Download here: idtb.io/ho3nff

Looking to understand how you can accelerate #proteinexpression and purification? Join us for a free webinar with @Aldevron and @Nuclera to see a streamlined, end-to-end solution that dramatically shortens the DNA-to-protein timeline. Register here: idtb.io/nia4ow

IDT’s new PrimeTime™ Influenza Kit and PrimeTime Research Pathogen Panels expand upon our current #infectiousdisease portfolio of #qPCR and #NGS solutions to support researchers exploring #viralevolution, #epidemiologicalstudies, #drugresistance mechanisms, #drugdevelopment

There’s still time to register! In this webinar, you will hear firsthand from Dr. Guseva from the University of Iowa on her experience using IDT Archer™ FUSIONPlex™ assays—why they chose IDT, how the assays were implemented, and how the workflow and analysis software improved

While it may be summer, we know your science never stops—we want you to have a little fun along the way. 🥼🌴 This summer, we're putting the excitement back into the lab with a season-long celebration of oligos, as part of our Sequence a Summer of Savings event. Join us for a

⭐FLEXIBLE NGS WORKFLOW COMPONENTS FOR RELIABLE CANCER RESEARCH INSIGHTS.⭐ ​The enhanced xGen™ Hyb and Wash Kit v3 was reconfigured to deliver a lower complexity workflow that reduces buffer steps, eliminates hot buffer handling, and supports lower library inputs—saving you

ATTENTION ALL MUSIC LOVERS—WE NEED YOUR HELP! 🎶 We’re putting together a Spotify playlist to keep the good times rolling both in and out of the lab. 😎 Tell us your song of the summer and we may add it to our playlist! 👇 Entries close on July 5 so be sure to lock your

We have made it to #ASMicrobe 2025! If you’re in LA, be sure to stop by booth #1723 to chat with IDT experts about our broad portfolio of qPCR primers for gene expression and pathogen research—including our new PrimeTime™ Research Pathogen Primers and Probes and the PrimeTime

⏳ Time is running out to register for our next webinar where we will present a streamlined, end-to-end solution that dramatically shortens the DNA-to-protein timeline with Aldevron and Nuclera. Interested? Learn more and register here: idtb.io/nia4ow #synbio